ANNX

3.1009.09%
DR

Dean R. Artis

Chief Scientific Officer & Executive VP

Dr. Dean R. Artis, also known as Rick, Ph.D., serves as Chief Scientific Officer and Executive Vice President at Annexon, Inc. since January 2023, where he is responsible for leading all research efforts, with a particular emphasis on the expansion of small molecule research and the further building of the robust pipeline. He was the Chief Scientific Officer of Octant, Inc. Before joining Octant in December 2021, he served as a Senior Vice President, Chemistry for Annexon Biosciences. He also served as the President and CSO of Chorum Pharmaceuticals. Prior to that, he led Molecular Discovery at Elan and served as its senior vice president of research. He served as the Vice President of lead generation at Plexxikon Inc. since November 2004. Dr. Artis was responsible for informatics, chemistry and structural biology. Dean joined Plexxikon in April 2002 as Senior Director of Informatics. Prior to Plexxikon, Artis held escalating positions with Genentech, most recently as Senior Scientist of structural chemistry, and previously was staff researcher of computer-aided drug design at Syntex. He has co-authored several papers, been recognized as a co-inventor on 45 issued U.S. patents and made direct contributions to seven molecules that have reached various stages of clinical development, including two that have received marketing approval. He holds a B.S. in Chemistry from the University of California, Berkeley and a Ph.D in organic chemistry from Yale University.

Positions